0001428369-12-000002.txt : 20121130
0001428369-12-000002.hdr.sgml : 20121130
20121130085502
ACCESSION NUMBER: 0001428369-12-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20121130
DATE AS OF CHANGE: 20121130
EFFECTIVENESS DATE: 20121130
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: THAR PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001428369
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-187681
FILM NUMBER: 121233238
BUSINESS ADDRESS:
STREET 1: 730 WILLIAM PITT WAY
CITY: PITTSBURGH
STATE: PA
ZIP: 15238
BUSINESS PHONE: 412-435-0200
MAIL ADDRESS:
STREET 1: 730 WILLIAM PITT WAY
CITY: PITTSBURGH
STATE: PA
ZIP: 15238
D
1
primary_doc.xml
X0706
D
LIVE
0001428369
THAR PHARMACEUTICALS INC
150 Gamma Drive
PITTSBURGH
PA
PENNSYLVANIA
15238
412-963-7500
DELAWARE
None
None
Corporation
true
2008
Raymond
Houck
c/o Thar Pharmaceuticals
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Executive Officer
Director
Lalit
Chordia
c/o Thar Pharmaceuticals, Inc.
150 Gamma Driv
Pittsburgh
PA
PENNSYLVANIA
15238
Director
Philip
Sussman
c/o Thar Pharmaceuticals, Inc.
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Director
Filip
Amram
c/o Thar Pharmaceuticals, Inc.
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Director
Mazen
Hanna
c/o Thar Pharmaceuticals, Inc.
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Executive Officer
Jason
Bablak
c/o Thar Pharmaceuticals, Inc.
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Executive Officer
Brian
Moyer
c/o Thar Pharmaceuticals, Inc.
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Executive Officer
Robert
Roy
c/o Thar Pharmaceuticals, Inc.
150 Gamma Drive
Pittsburgh
PA
PENNSYLVANIA
15238
Director
Pharmaceuticals
No Revenues
- 06
false
2011-10-26
false
true
true
true
false
50000
2000000
405000
1595000
false
6
0
0
450000
true
A use of proceeds is working capital, which use includes salaries of executive officers.
false
THAR PHARMACEUTICALS INC
Brian Moyer
Brian Moyer
Vice President, Corporate Development
2012-11-30